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Abstract
Arrhythmogenic cardiomyopathy (AC), also known as arrhythmogenic right ventricular
cardiomyopathy (ARVC), is a disease characterized by fatty or fibro-fatty myocardial
replacement, predominantly in the right ventricle and to a lower extent the left ventricle. It is
recognized as a disease affecting the cardiac intercalated disc. Clinically, it is associated with
ventricular arrhythmias, although atrial arrhythmias and atrial histopathological changes
characteristic of AC have occasionally been reported. The full extent of atrial involvement in AC
has not been investigated. Therefore, we aimed to apply histopathology, immunochemical
detection, immunolocalization and transmission electron microscopy (TEM) techniques to
characterize the distribution of desmosomal and gap junction proteins at the intercalated disc in
the atria of boxers with AC. We hypothesized that histological changes consistent with AC and
alterations to the intercalated disc proteins are present in the atria of boxer dogs with AC. The
hearts from 14 control and 13 boxers with confirmed AC were studied. Right and left atrial
sections from 11 boxers were examined by immunofluorescence. Samples from 10 boxers were
used for Western blot analysis. The intercalated disc proteins investigated were connexin 43
(Cx43), connexin 45, connexin 40, plakoglobin, plakophilin-2, desmoplakin, and cadherin.
Transmission electron microscopy was performed on the right and left atrial sections of 2 boxers
and 2 controls. Western blot band relative density indicated a significant decrease of Cx43 in the
right atrium of affected boxers compared to controls. There was no difference between controls
and boxers for the other proteins investigated. Immunofluorescence analysis showed that the
number of Cx43 signals and the signal intensity for plakoglobin was decreased in the left and
right atrium of affected boxers. Transmission electron microscopy suggested disruption of the
intercalated disc in affected boxers. In conclusion, these results indicate the alteration of
intercalated disc proteins in the atrial myocardium of boxers, showing atrial involvement in
vii

addition to the ventricles. These findings support the use of the broader term of AC rather than
ARVC to describe this disease. The decrease in the amount of Cx43 in conjunction with the
histological changes could represent the substrate for the atrial arrhythmias associated with AC.
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Chapter 1
Introduction
Arrhythmogenic cardiomyopathy (AC) is a myocardial disease characterized by
ventricular arrhythmias, syncopal episodes and sudden death in human patients (Corrado, Basso
et al. 2000). The disease was originally described as a developmental condition affecting the
right ventricle, and was therefore termed arrhythmogenic right ventricular dysplasia (Marcus,
Fontaine et al. 1982). However, as the understanding of the disease has changed, so has the name
of the disease. The use of the term arrhythmogenic right ventricular cardiomyopathy (ARVC)
became more common when it was recognized as a progressive cardiomyopathy, characterized
by fatty or fibro-fatty replacement of the right ventricular myocardium, suggestive of an injury
and repair process (Basso, Thiene et al. 1996). Most recently, it has been shown that although
the disease affects primarily the right ventricle, there is significant involvement of the left
ventricular myocardium (Norman, Simpson et al. 2005). Currently, it is widely accepted that
both ventricles can be affected by the disease, which has led to an expert consensus and the
suggestion to change the nomenclature of the disease from arrhythmogenic right ventricular
cardiomyopathy to the broader term of arrhythmogenic cardiomyopathy (Basso, Corrado et al.
2009; Sen-Chowdhry, Morgan et al. 2010). The disease has also been recognized in dogs, with
boxer dogs being more commonly affected (Basso, Fox et al. 2004).
In humans, arrhythmogenic cardiomyopathy has been linked to mutations of genes
coding for proteins of the desmosomes in the intercalated disc (Marcus, McKenna et al. 2010;
Corrado, Basso et al. 2011). The intercalated disc is responsible for cell adhesion between
cardiomyocytes and is formed by three types of intercellular connections: desmosomes, adherens
junctions and gap junctions. The desmosomes and adherens junctions are responsible for the
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mechanical coupling between cardiac myocytes; the gap junctions facilitate cell-to-cell
propagation of the electrical impulse. Mutations in the genes coding for plakoglobin (JUP),
desmoplakin (DP), plakophilin-2 (PKP2), desmoglein-2 and desmocollin-2, all proteins of the
desmosomes, have been linked to AC in humans (Rampazzo, Nava et al. 2002; Gerull, Heuser et
al. 2004; Heuser, Plovie et al. 2006; Pilichou, Nava et al. 2006). Immunofluorescence of
ventricular tissue in humans and boxers with AC has shown a decrease in the signal of various
desmosomal proteins at the level of the intercalated disc, which is more pronounced for
plakoglobin (Oxford, Everitt et al. 2007; Asimaki, Tandri et al. 2009). Moreover, transmission
electron microscopy (TEM) has shown a decrease in the number of desmosomes in the right
ventricle of both humans and boxers with AC (Basso, Czarnowska et al. 2006; Oxford, Danko et
al. 2011). In addition to the desmosomes, gap junctions are also affected by AC. Decreased
expression and altered localization of connexin 43 (Cx43), a protein of the gap junctions, has
been identified via immunofluorescence of ventricular tissue in humans and boxers with AC
(Kaplan, Gard et al. 2004; Oxford, Everitt et al. 2007). Transmission electron microscopy of left
and right ventricular samples of boxers with AC confirmed a decrease in the number of gap
junctions at the level of the intercalated disc (Oxford, Danko et al. 2011). Alterations of gap
junctions have been linked to arrhythmogenesis and could contribute to the arrhythmias seen
with AC (Severs, Bruce et al. 2008; Basso, Corrado et al. 2009)
During evaluation of boxers presented to the cardiology services of Louisiana
State and Cornell University, it was noticed that, in addition to the ventricular arrhythmias, some
boxers with AC also have atrial arrhythmias. Atrial arrhythmias and sinus node dysfunction
have occasionally been reported in humans and boxers with AC (Harpster 1983; Nogami, Adachi
et al. 1990; Takemura, Kono et al. 2008; Thomason, Kraus et al. 2008; Chu, Zado et al. 2010). It
2

is possible that these atrial arrhythmias could be the cause of syncopal episodes in some boxers
with AC. Syncopal episodes as a result of bradyarrhythmias and sinus node dysfunction have
been reported previously in boxers with ventricular tachycardia (Thomason, Kraus et al. 2008).
Atrial histopathological changes consistent with AC have been reported before in both humans
and boxer dogs (Nogami, Adachi et al. 1990; Basso, Fox et al. 2004). However, careful
evaluation of the atrial tissue in AC has not been performed. Therefore, the degree to which AC
can affect the atrial myocardium is unknown.
We aimed to investigate if the atrial myocardium of boxers with AC is affected by the
disease and whether alterations in the desmosomal and gap junction proteins at the level of the
intercalated disc are present in the atrial tissue of boxers with AC. We explored this question by
using histopathology, immunochemical detection, immunolocalization, and TEM to characterize
the distribution of desmosomal and gap junction proteins at the level of the intercalated disc in
boxer dogs. We hypothesized that histological changes consistent with AC and alterations of the
proteins of the intercalated disc are present in the atria of boxer dogs with AC. If present, these
changes could be responsible for the atrial arrhythmias seen with AC.
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Chapter 2
Literature Review
Historical perspective on arrhythmogenic cardiomyopathy
In people, arrhythmogenic cardiomyopathy is an inherited myocardial disease
characterized by fatty or fibro-fatty replacement of the right ventricular myocardium and is
associated with ventricular arrhythmias and sudden death (McKenna, Thiene et al. 1994;
Richardson, McKenna et al. 1996; Fontaine, Fontaliran et al. 1998). Early pathological changes
may be limited to an area demarcated by the free wall of the right ventricular inflow tract,
outflow tract and apex, known as the “triangle of dysplasia” (Marcus, Fontaine et al. 1982;
Marcus, McKenna et al. 2010). Progression of the disease leads to broader right ventricular
involvement and in many cases, left ventricular involvement as well (Corrado, Basso et al.
1997). In 1982, Marcus et al. reported 24 cases of right ventricular dysplasia with fatty
replacement of the right ventricle (Marcus, Fontaine et al. 1982). At the time, the disease was
believed to be a developmental disorder, hence its designation as ventricular dysplasia (Basso,
Thiene et al. 1996; Azaouagh, Churzidse et al. 2011). Thiene et al. described the autosomal
pattern of inheritance of AC in a group of people from Veneto, a northeast region of Italy, in
1988 (Thiene, Nava et al. 1988). These affected individuals suffered from a right ventricular
cardiomyopathy with ventricular arrhythmias leading to palpitations or syncopal episodes.
However, in many of these individuals, sudden death was the first sign of disease. Human
disease prevalence varies based on geographical location but it has been estimated to range from
1:1000 to 1:5000 individuals (Basso, Corrado et al. 2009; Marcus, McKenna et al. 2010).
In veterinary medicine, AC is mainly thought of as a canine disease, although the first
veterinary report of AC was made in a group of cats in 2000 (Fox, Maron et al. 2000). However
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before this report, a primary myocardial disease, characterized by ventricular arrhythmias,
syncope episodes and sudden death had long been described in boxer dogs and termed “boxer
cardiomyopathy” (Harpster 1983; Harpster 1991). Pedigree analysis of boxers affected by
ventricular arrhythmias has shown that these ventricular arrhythmias are inherited as an
autosomal dominant trait in certain boxers (Meurs, Spier et al. 1999). It is likely that these early
reports of “boxer cardiomyopathy” and inherited ventricular arrhythmias corresponded to a
manifestation of AC. In 2004, Basso et al. first suggested that “boxer cardiomyopathy” may be a
possible animal model of AC (Basso, Fox et al. 2004). They described the spontaneously
occurring inherited “boxer cardiomyopathy” as being characterized by fibro-fatty infiltration of
the right ventricular myocardium, and to a lesser extent the left ventricular and atrial
myocardium. Clinically, the disease was characterized by ventricular tachycardia, right
ventricular enlargement, syncope and sudden death, resembling the manifestation of AC in
humans. AC has also been documented, although less frequently, in other breeds including
English bulldogs (Santilli, Bontempi et al. 2009; Santilli, Bontempi et al. 2011).
Clinical perspective on arrhythmogenic cardiomyopathy
The clinical presentation of AC is similar in both humans and animals. There are three
stages to the disease that are usually observed in succession as AC worsens: 1) Initially, the
patient is asymptomatic and ventricular arrhythmias are an incidental finding during physical
examination for an unrelated condition. 2) The patient presents for signs associated with
ventricular arrhythmias, including syncope, episodic weakness or palpitations (in humans). 3)
The patient presents with signs of congestive heart failure secondary to systolic dysfunction and
frequently a history of weakness or syncope related to the arrhythmias (Harpster 1983; Harpster
1991; Meurs 2004; Marcus, McKenna et al. 2010). However, as previously mentioned, in some
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cases sudden death is the first and only sign of the disease. In this disease, arrhythmias seem to
be triggered by strenuous activity (Azaouagh, Churzidse et al. 2011). Therefore, people
diagnosed with AC are encouraged not to participate in sports.
The most common physical examination finding reported, in both boxers and humans, is
the detection of an arrhythmia; this can be either single premature beats or paroxysms of
tachycardia. On occasion, the arrhythmia is permanent when atrial fibrillation is present.
Another physical examination abnormality common with AC is the presence of a systolic
murmur on auscultation. Apical systolic murmurs result from mitral or tricuspid insufficiency
from the annular dilation that accompanies cardiomegaly. Less frequently, a cardiac gallop is
detected (Harpster 1983; Harpster 1991; Meurs 2004). Left basilar systolic murmurs may be
noted in some boxers, but these should not be linked to AC as they are usually physiologic or
secondary to subaortic stenosis (Meurs 2004; Hariau and Carpenter 2010).
Electrocardiography (ECG) plays an integral part in the clinical diagnosis of AC. The
most common electrocardiographic change noted is ventricular ectopy, in the form of ventricular
premature complexes (singles, couplets, triplets or bigeminy) or ventricular tachycardia. The
ventricular ectopic beats tend to arise from the right ventricular myocardium, and are classically
described as having a left bundle branch block pattern morphology with a predominantly positive
deflection of the QRS complex in leads II, III and aVF (Kraus, Moïse et al. 2002; Basso, Fox et
al. 2004; Meurs 2004; Cox, van der Smagt et al. 2009). If severe, the ventricular tachycardia can
lead to syncopal episodes and potentially sudden death. The presence of conduction
abnormalities manifested as abnormal late potentials measured by signal averaged
electrocardiography has also been associated with AC in both humans and boxers (Spier and
Meurs 2004; Marcus, McKenna et al. 2010). Humans with AC can also have prolonged P-wave
6

duration and abnormalities in P-wave morphology, suggesting that the conduction abnormalities
are not limited to the ventricles and that the atria may also be affected (Platonov, Christensen et
al. 2011). In both humans and boxers with AC, atrial arrhythmias such as supraventricular
tachycardia and atrial fibrillation have been reported to occur occasionally; atrioventricular block
and sinus node dysfunction have been observed infrequently (Harpster 1983; Nogami, Adachi et
al. 1990; Harpster 1991; Baumwart, Meurs et al. 2005; Takemura, Kono et al. 2008; Thomason,
Kraus et al. 2008; Chu, Zado et al. 2010). If severe enough, these atrial arrhythmias could also
lead to syncope or contribute to the progression to heart failure in human and veterinary patients
afflicted with AC. Because arrhythmias can occur intermittently, AC should not be ruled out if
they are absent on a screening electrocardiogram. The frequency of the ventricular beats can
have as much as an 80% day to day variation with AC (Spier and Meurs 2004). To increase the
possibility of identifying these arrhythmias, 24-hour Holter monitoring is recommended if there
is evidence of arrhythmia on auscultation or a history of clinical signs such as syncope (Meurs
2004). On occasion, it may be necessary to perform additional Holter recordings or use an event
monitor to increase the likelihood of arrhythmia detection (Meurs and Spier 2009). In humans,
the presence of >500 ventricular beats in 24 hours is considered in the criteria for the diagnosis
of AC (Corrado, Basso et al. 2011). In boxers the presence of >100 ventricular beats in 24 hours
is suggestive of AC, especially if these ectopic beats are present in the form of couplets, triplets,
bigeminy or ventricular tachycardia (Meurs and Spier 2009; Stern, Meurs et al. 2010). A Holter
monitoring screening scheme has been suggested by Meurs et al., based on the number of
ventricular premature complexes (VPCs) per 24 hours of 600 asymptomatic boxer dogs. It
separates the affected animals into 5 groups: 1) 0-50 VPCs; within normal limits 2) 51-100
VPCs; indeterminate 3) 100-300 VPCs; suspicious 4) 100-300 VPCs with increased complexity
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(couplets, triplets or ventricular tachycardia) or 300-1000 VPCs; likely affected 5) Greater than
1000 VPCs; affected, consider treatment (Meurs and Spier 2009). This classification should not
be used alone but instead combined with all the other diagnostic findings before making
recommendations. It should be noted that neither the number of VPCs nor the complexity of the
arrhythmias can be used as a sole factor to predict the risk of an animal to become symptomatic
for the disease (Meurs and Spier 2009).
Echocardiographic findings of AC can be highly variable. Although AC is a primary
myocardial disease, structural changes may only be present on histopathology and not be evident
on echocardiography (Meurs 2004). The expected findings on echocardiography vary depending
on the stage of disease progression. The majority of asymptomatic boxers, as well as most dogs
suffering from syncopal episodes, have normal echocardiograms, but signs of depressed
ventricular function and chamber dilation are reported on occasion. Atrial enlargement also
develops as a result of ventricular dysfunction, and is more pronounced in dogs with congestive
heart failure. Although the complex shape and mechanical properties of the right ventricle
prevents accurate and systematic evaluation via echocardiography (Baumwart, Meurs et al.
2009), careful examination of the right side of the heart of affected dogs may reveal localized
right ventricular dilation and dysfunction (Santilli, Bontempi et al. 2011). Increases in right
ventricular inflow and right ventricular outflow tract dimensions are typically noted during
echocardiography in humans with AC, with approximately 62% of the patients having abnormal
right ventricular function (Yoerger, Marcus et al. 2005). Right ventricular outflow tract dilation
in combination with regional right ventricular akinesia, dyskinesia, or aneurysm are part of the
echocardiographic diagnosis criteria of AC in humans (Marcus, McKenna et al. 2010).
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Decreased right ventricular ejection fraction has been shown in AC boxers when
measured via ECG- gated magnetic resonance imaging (Baumwart, Meurs et al. 2009).
Ultimately, disease progression may lead to biventricular failure, making it difficult to
distinguish AC from idiopathic dilated cardiomyopathy (Corrado, Basso et al. 1997; Corrado,
Basso et al. 2000; Baumwart, Meurs et al. 2005; Marcus, McKenna et al. 2010).
Because of the difficulty in diagnosing AC, as well as its multiple possible
manifestations, a list of diagnostic criteria was created for AC in humans in 1994. The “Task
Force Criteria” combine data collected from multiple diagnostic tools, including ECG,
echocardiography, genetic testing, and histopathology to establish a clinical diagnosis of AC
(McKenna, Thiene et al. 1994; Corrado, Basso et al. 2011). The findings from these tests are
divided into a set of major and minor criteria for the diagnosis of AC (Table 1.1). A positive
diagnosis of AC based on the list of “Task Force Criteria” necessitates the presence of two major
criteria, one major plus two minor criteria or four minor criteria (McKenna, Thiene et al. 1994).
The criteria were recently updated to incorporate recent advances, thereby increasing
their diagnostic potential while maintaining their specificity for the disease (Marcus, McKenna et
al. 2010). The modified list gives more emphasis to the family history of the patient. Indeed, a
family history of confirmed disease increases the likelihood of disease in an individual from
1:1000-1:5000 to 1:2 (Marcus, McKenna et al. 2010). Because the “Task Force Criteria” were
designed for the diagnosis of AC in humans, there are a number of factors that cannot be easily
applied to boxers with AC. However, others are shared between humans and boxers, which
makes these guidelines useful for the diagnosis of AC in boxers.
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Table 1.1. Original Task Force Criteria
Major

Minor

Global or regional dysfunction and structural alteration




Severe dilation and reduction of RV ejection
fraction with no (or only mild) LV impairment
Localized RV aneurysms (akinetic or dyskinetic
areas with diastolic bulging)
Severe segmental dilation of the RV





Mild global RV dilation and/or ejection fraction
reduction with normal LV
Mild segmental dilation of the RV
Regional RV hypokinesia

Tissue characterization of wall


Fibrofatty replacement of myocardium on
endomyocardial biopsy

Repolarization abnormalities


Inverted T waves in right precordial leads (V2 and
V3) (people age > 12 years, in the absence of right
bundle-branch block)

Depolarization/conduction abnormalities


Epsilon Waves or localized prolongation (>110
ms) of the QRS complex in right precordial leads
(V1 to V3)



Late potentials (signal averaged ECG)

Arrhythmias



Left bundle-branch block-type ventricular
tachycardia (sustained and nonsustained) (ECG,
Holter, exercise)
Frequent ventricular extrasystoles (>1000 per 24
hours) (Holter)

Family history


Familial disease confirmed at necropsy or surgery
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Family history of premature sudden death (<35
years of age) due to suspected AC
Familial history (clinical diagnosis based on
present criteria)

Criteria of particular interest for the diagnosis of AC in boxers include the presence of
sustained or nonsustained ventricular tachycardia with left bundle branch block morphology, the
number of ventricular beats in a 24-hour period, the presence of a family history of the disease,
the finding of regional structural or functional changes via imaging (echocardiography, MRI),
and histopathology showing fatty or fibro-fatty replacement of the ventricular myocardium.
Among all the different factors evaluated by the group forming the task force, histopathological
evaluation of the myocardium remained the gold standard for a definitive diagnosis of AC
(McKenna, Thiene et al. 1994; Marcus, McKenna et al. 2010).
Treatment of AC aims at alleviating the clinical signs, as there is no specific treatment for
the disease. In the absence of clinical signs and if the arrhythmia burden is mild, no treatment
may be necessary. However, if the arrhythmia is of clinical concern or if there are collapsing
episodes, antiarrhythmic therapy is implemented. In dogs, common protocols for the treatment of
ventricular arrhythmias include the use of sotalol monotherapy or a combination of mexiletine
and a -blocker (Meurs and Spier 2009). The response to antiarrhythmic therapy should be
assessed via 24-hour Holter monitoring, keeping in mind that there could be as much as an 80%
daily variation in the number of ventricular ectopies in dogs with AC (Spier and Meurs 2004). In
cases where congestive heart failure is present, standard heart failure therapy is initiated with the
need for addition of antiarrhythmic therapy determined by the patients underlying rhythm. The
administration of antiarrhythmic drugs can lead to a reduction in clinical signs and therefore
improve quality of life but the risk for sudden death from AC is not decreased by these
medications. In boxers, the use of antiarrhythmic medications as the sole therapy for controlling
these malignant arrhythmias is the current standard of care. However, in humans the use of
implantable cardioverter defibrillators (ICDs) in combination with antiarrhythmic medications is
11

recommended in individuals with syncope or hemodynamically unstable ventricular tachycardia
to reduce the clinical signs and the risk of sudden death associated with AC (Azaouagh,
Churzidse et al. 2011; Corrado, Basso et al. 2011). Implantable cardioverter defibrillator (ICD)
therapy is not widely available in dogs and its clinical use is limited to a few case reports
(Nelson, Lahmers et al. 2006; Pariaut, Saelinger et al. 2011). A recent study, evaluating the use
of ICDs in 9 healthy dogs showed that ICDs can be safely implanted in dogs with adequate
safety margins allowing successful defibrillation therapy (Pariaut, Saelinger et al. 2012).
However, additional research is needed to improve ICD therapy in dogs. With continued
research, ICD therapy may become more available in veterinary medicine, and it may become an
important tool in the treatment of AC.
Histopathological perspective on arrhythmogenic cardiomyopathy
The typical histopathological changes associated with AC are fatty or fibro-fatty
replacement of the right ventricular myocardium, which exhibits features of myocyte
degeneration and death suggesting an injury and repair process (Basso, Thiene et al. 1996; Basso
and Thiene 2005). The fatty or fibro-fatty replacement of the myocardium tends to start in the
subepicardium, extending to the midmyocardium and eventually becoming transmural as the
disease progresses (Basso, Corrado et al. 2009). Fatty infiltration of the right ventricle alone
should not be considered as a sole diagnostic factor of AC as some intramyocardial fat can be a
normal finding in the right ventricle (Azaouagh, Churzidse et al. 2011). Also, in both the fatty
and fibro-fatty form of AC, there will be some degree of degenerative changes of the myocytes
as well as interstitial fibrosis histologically (Basso and Thiene 2005). What has been viewed as
“the classic” form of AC, is a disease process that would affect primarily the right ventricle.
However, involvement of the left ventricular myocardium has been well documented in both 76
12

% of humans and 48 % of boxers with AC (Corrado, Basso et al. 1997; Basso, Fox et al. 2004).
Fatty or fibro-fatty changes in the left and right atrial tissue have also been reported in AC with 8
out of 23 boxers (35%) having atrial changes in the first report of AC in this breed (Basso, Fox et
al. 2004). Atrial changes have been documented in humans case reports; however, research
studies of atrial tissues are not available probably due to inadequate examination of atrial tissues
(Nogami, Adachi et al. 1990; Corrado, Basso et al. 1997). In addition to the typical fatty or
fibro-fatty replacement, myocarditis associated with apoptosis has been commonly documented
in humans and boxers with AC, with the fibro-fatty form of the disease showing a higher
occurrence of myocarditis (Basso, Thiene et al. 1996; Basso, Fox et al. 2004). In the first report
of AC in boxers, focal or multifocal lymphocytic infiltrates characteristic of myocarditis were
reported in the right ventricle (61%), left ventricle (70%), and atria (17%) of AC boxers (Basso,
Fox et al. 2004). At this time, it has not been determined whether myocarditis is a reaction to cell
death or contributes to it (Basso, Thiene et al. 1996; Corrado, Basso et al. 2011). However, it is
believed that myocarditis in AC patients could be a factor in the development of life-threatening
arrhythmias (Basso, Fox et al. 2004; Corrado, Basso et al. 2011). Despite the importance of
histopathology for a final diagnosis of AC, the clinical diagnosis of AC should be based on the
combination of the clinical criteria described by the “Task force”. Histopathological evaluation
requires an invasive procedure, such as endomyocardial biopsy, that may not be feasible in all
patients, especially in veterinary medicine. In addition, although diagnosis is definitive when
fatty or fibro-fatty myocardial replacement is present, segmental involvement of the myocardium
could lead to false negative diagnosis considering the small size of the biopsy samples (Marcus,
McKenna et al. 2010; Azaouagh, Churzidse et al. 2011).
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Molecular perspective on arrhythmogenic cardiomyopathy
In humans, AC is usually found to be an autosomal dominant inherited disease with
incomplete penetrance. In addition, there are some recessive forms, Naxos disease and Carvajal
syndrome, that are associated with skin lesions (Kaplan, Gard et al. 2004; Marcus, McKenna et
al. 2010). In 1998, Naxos disease was mapped to chromosome 17 (Coonar, Protonotarios et al.
1998). The external phenotype of the disease made it ideal for the study of AC as cardiac
disease could be assertively assigned by the presence of the skin and hair changes (McKoy,
Protonotarios et al. 2000). As a matter of fact, it was the study of this disease that introduced the
idea that AC could be a cell junction disease. In 2000, the first AC gene mutation was identified,
when McKoy et al. discovered that a mutation in the Plakoglobin gene, affecting the C-terminal
of the protein, was responsible for Naxos disease (McKoy, Protonotarios et al. 2000).
Plakoglobin is an important protein for the formation of cell-to-cell connections in many tissues.
The fact that the skin and the heart share similar cell-to-cell connections explains how a mutation
in a single gene, corresponding to a protein of the desmosome and adherens junctions, can cause
clinical signs associated with both organs. Currently, it is widely accepted that AC is a disease
of the intercalated disc and more specifically of the desmosomes that compose it. The
intercalated discs are the end-to-end connection of cardiomyocytes and are formed by three types
of intercellular junctions: desmosomes, adherens junctions and gap junctions. The desmosomes
and adherens junctions are primarily responsible for the mechanical coupling between
cardiomyocytes, whereas the gap junctions facilitate cell-to-cell electrical impulse propagation.
In recent years, mutations in many more genes that code for proteins of the desmosomes and
adherens junctions have been shown to be the cause of AC. For example, a mutation in
desmoplakin (a desmosomal protein) has been identified as the cause for Carvajal syndrome
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(Norgett, Hatsell et al. 2000). Autosomal dominant mutations in plakoglobin (JUP),
desmoplakin (DP), plakophilin-2 (PKP2), desmoglein-2 and desmocollin-2, all proteins of the
desmosome, have subsequently been linked to AC in humans (Rampazzo, Nava et al. 2002;
Gerull, Heuser et al. 2004; Heuser, Plovie et al. 2006; Pilichou, Nava et al. 2006). In 2005,
Norman et al. described a dominant mutation in desmoplakin that produces a primarily left-sided
form of AC (Norman, Simpson et al. 2005). In addition to the mutations of desmosomal
proteins, mutations in the genes coding for the ryanodine receptor (RYR2) and transforming
growth factor beta-3 have also been reported to be associated with AC (Tiso, Stephan et al. 2001;
Beffagna, Occhi et al. 2005). The latest gene to be identified as a cause of AC was the
transmembrane protein 43 (TMEM43) gene; little is known about this gene at this time but it is
suspected to play a role in an adipogenic pathway (Merner, Hodgkinson et al. 2008; Corrado,
Basso et al. 2011). Despite the discovery of many of the genes that can lead to AC, currently
over 50% of patients with AC still do not have an identifiable genetic mutation (Saffitz 2009). In
boxers with AC, a reduction in the right and left ventricular expression of the ryanodine receptor
and the left ventricular levels of calstabin-2, a protein that modulates the RYR2 receptor
function, have been demonstrated (Meurs, Lacombe et al. 2006; Oyama, Reiken et al. 2008).
However, only one genetic mutation has been associated with AC to date, the striatin gene that
codes for a protein that colocalizes with JUP, PKP2, and DP in the intercalated disc (Meurs,
Mauceli et al. 2010). In this study, boxers positive for the striatin mutation had a higher number
of VPCs on 24 hour Holters, with homozygous dogs being more affected than dogs that are
heterozygous for the mutation. Immunofluorescence of ventricular tissue in AC boxers has
shown decreased signal for PKP2, DP, and a complete lack of JUP in the intercalated disc
(Oxford, Everitt et al. 2007). Immunofluorescence has gained interest as a reliable way to show

15

the altered desmosomal proteins, helping in the diagnosis of AC. In fact, in humans,
immunofluorescence for JUP has been shown to have 91% sensitivity and 82% specificity as a
diagnostic test for AC (Asimaki, Tandri et al. 2009). It has been suggested that
immunofluorescence for desmosomal proteins, like JUP, could be incorporated into the
diagnostic criteria in the future. Transmission electron microscopy has also been used to
evaluate the intercalated disc area in both boxers and humans, showing a significantly lower
number of desmosomes the right ventricle of AC affected individuals compared to controls
(Basso, Czarnowska et al. 2006; Oxford, Danko et al. 2011). The fact that over 50% of humans
do not have an identifiable genetic mutation and that boxers have decreased immunofluorescence
signal for some desmosomal proteins, similar to human AC patients with confirmed genetic
mutations, suggests that the desmosomal proteins in boxers with AC are also defective, even if a
specific genetic mutation in these proteins has not been discovered at this time.
In humans, not all individuals in which a genetic mutation linked to AC is present will
develop the phenotypical changes associated with the disease given the incomplete penetrance
and variable expression of these genes (Corrado, Basso et al. 2011). Despite the recognition of
AC as a disease of the cardiac desmosomes, the specific mechanism of how disruption of these
desmosomal proteins leads to AC is still unknown. The most accepted hypothesis is that the
integration of defective desmosomal proteins into the intercalated disc facilitates the detachment
of myocytes at this location, especially during periods of mechanical stress, leading to the
degeneration and apoptosis of cardiomyocytes with development of fibro-fatty replacement as a
result of the repair process (Corrado, Basso et al. 2011). Because the desmosomes and adherens
junctions provide the mechanical connection between myocytes, it seems logical that disruption
to their integrity would lead to myocyte detachment and damage. However, to view this as a
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simple mechanical cause and effect scenario could be oversimplifying what actually occurs, as it
has also been shown that intercalated disc proteins have a complex interaction with each other
and can also play a part in signaling pathways. Desmosomes have been proposed to regulate
transcription genes involved in adipogenesis and apoptosis. For example, it has been suggested
that nuclear translocation of plakoglobin, in desmoplakin deficient mice, mediates changes in the
Wnt pathway causing the differentiation of cardiomyocytes into the adipocyte lineage (GarciaGras, Lombardi et al. 2006; Delmar and McKenna 2010). Decreases in Ankaryn-G, a
cytoskeletal adaptor protein that is associated with the voltage-gated sodium channels at the
intercalated disc, in cultured myocytes has been shown to lead to decreased PKP-2 expression
and decreased intercellular adhesion strength (Sato, Coombs et al. 2011). Interestingly, a
reciprocal relationship was also noted with a decrease in PKP-2 leading to a decrease in
Ankaryn-G expression and decreased intercellular adhesion strength (Sato, Coombs et al. 2011).
This serves to illustrate the complex and yet incompletely understood interaction between
intercalated disc proteins that were previously viewed as independent complexes located within
the same general area (Delmar 2012). Therefore, it is likely that the combination of the
mechanical forces, the interaction of the mutated desmosomal proteins with other intercalated
disc components and signaling pathways lead to the altered intercalated disc integrity rather than
any one mechanism on its own.
Because of the previously discussed interaction between the intercalated disc
components, genetic mutations affecting the desmosomal proteins do not only alter the integrity
of the desmosomes and adherens junctions but also lead to altered gap junctions as these
connections are usually found adjacent to the desmosomes in the intercalated disc. Gap junctions
are composed of a collection of intercellular channels. Each intercellular channel is composed of
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a pair of connexons on each side of the plasma membrane. Each connexon is composed of six
connexin molecules. There are 3 main connexin proteins expressed in cardiac tissue: connexin
40 (Cx40), connexin 43 (Cx43) and connexin 45 (Cx45) (Severs, Bruce et al. 2008). Connexin
43 is the main connexin found in the gap junctions of ventricular tissue (Davis, Kanter et al.
1994). Immunofluorescence analysis of ventricular tissue in both affected humans and boxers
has shown decreased Cx43 expression and altered localization, to the lateral aspect of the
myocytes instead of forming part of the end to end connections (Kaplan, Gard et al. 2004;
Oxford, Everitt et al. 2007). These findings have also been confirmed via transmission electron
microscopy with AC affected boxers having a decrease in the number of gap junctions at the
level of the intercalated disc in both the right and left ventricle (Oxford, Danko et al. 2011). Gap
junctions only provide the electrical connection between cells and have been described as being
particularly susceptible to shear stress (Saffitz, Hames et al. 2007). Therefore, once the
mechanical connection provided by desmosomes and adherens junctions has been disrupted, the
gap junctions are not able to sustain the remaining forces. Another theory on how damage to the
desmosome affects the gap junction integrity is that the gap junction and desmosome are not two
independent components of the intercalated disc but that on the other hand they are
interconnected with molecular changes to one affecting the other. An example of this can be
seen by the fact that decreased expression of PKP-2 in cultured myocytes leads to decreased
Cx43 expression, suggesting that increased shear stress is not the only factor altering gap
junction expression in AC (Oxford, Musa et al. 2007). Gap junction remodeling is not limited to
the disease process in AC, but can occur as a consequence of disruption to the intercalated disc
or cardiomyocyte integrity, as decreases and lateralization of gap junctions have also been shown
to occur secondary to CHF in other cardiovascular diseases (Severs, Bruce et al. 2008).
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Therefore, the alterations in gap junctions could be directly related to the pathogenesis of AC or
a result of end stage disease leading to a “final common pathway” of disease regardless of the
cause of cardiomyopathy (Vatta, Marcus et al. 2007). However, alterations to the gap junctions
have been shown to occur in AC before the presence of cardiac pathology (Kaplan, Gard et al.
2004), suggesting that they are part of the initial pathological process in AC even if they also
occur in the end stages of other cardiac diseases. Irrespective of the reason for gap junction
alteration, it has been shown that alterations in their function and location can lead to
arrhythmogenesis (Severs, Bruce et al. 2008). For example, in a chimeric mouse model,
heterogeneous Cx43 expression in the myocardium was linked to conduction abnormalities,
contractile dysfunction, and occasional ventricular tachycardia (Gutstein, Morley et al. 2001).
Therefore, it is likely that altered gap junction expression and localization contribute to the
arrhythmogenic substrate created by the fatty or fibro-fatty infiltration of the myocardium in AC.
In conclusion, AC is a disease dominated by ventricular arrhythmias. The substrate for
these arrhythmias is likely a combination of the diffuse fatty or fibro-fatty myocardial
replacement and an alteration in gap junction number and location at the molecular level. While
most of the attention has been directed to the life-threatening ventricular arrhythmias, one cannot
ignore the occurrence of atrial arrhythmias with AC. Therefore, we aim to investigate if the
atrial myocardium of AC boxers is affected by the disease and whether alterations in
desmosomal proteins and gap junctions can be detected in this tissue, potentially representing the
anatomic substrate for the atrial arrhythmias.
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Chapter 3
Materials and Methods
Samples
Tissues were collected from 13 boxer dogs with a clinical diagnosis of AC at 3
institutions, Louisiana State University, Cornell University and the University of Pennsylvania.
Sample collection took place less than one hour after sudden death or euthanasia at the owner’s
request because of concurrent disease or heart disease for which the prognosis was poor. Control
samples from 14 mongrel dogs without cardiac disease, based on physical examination, heart
weight to body weight ratio and gross examination of the hearts were obtained after euthanasia
for a separate study. Ten boxers had echocardiograms and 10 boxers had 24-Holter recordings
available for a detailed analysis and quantification of arrhythmias. Genetic testing was performed
as part of the clinical evaluation in 5 boxers. Full thickness right ventricular, left and right atrial
samples were obtained. The samples were flash-frozen and saved at -80 ºC for western blot;
fixed in 10% phosphate-buffered formalin and embedded in paraffin for histopathology and
immunofluorescence; fixed in 1.25% gluteraldehyde and 2% formaldehyde in Cacodylate buffer
(CAC) for transmission electron microscopy.
Pathology
Sections were cut in 5-µm thick slices. The left and right atria from all dogs were stained
with hematoxylin and eosin for routine histopathologic evaluation and Masson trichrome to
better characterize fibro-fatty infiltrates. The right ventricle of boxer dogs was also stained in a
similar fashion to corroborate the diagnosis of AC. All the samples were classified as normal or
as having fibro or fibro-fatty replacement by a blinded single investigator with expertise in
cardiac pathology who was not aware of the group status.
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Localization of intercalated disc proteins by immunofluorescence
Immunofluorescence was performed on full thickness left and right atrial samples of 14
control and 11 boxer dogs. The samples were fixed in 10% buffered formalin, embedded in
paraffin and sectioned into 5-µm thick slices. Sections were deparaffinized and antigen retrieval
performed with citrate buffer. Sections were blocked in 10% normal goat serum (Invitrogen,
Carlsbad, CA) or 5% bovine serum albumin, 0.1% triton buffer for 90 minutes, and then
incubated overnight at 4°C with the appropriate primary antibodies. After incubation, the
samples were washed in phosphate-buffered saline (PBS) and incubated with the appropriate
secondary antibodies for 1 hour at room temperature. The samples were mounted with
VECTASHIELD Mounting Medium with DAPI (Vector Laboratories, Inc., Burlingame, CA)
and examined with an Olympus IX71 inverted microscope. The secondary antibodies used were
Alexafluor 484 goat anti-rabbit and Alexafluor 598 goat anti-mouse (Molecular Probes, Division
of Invitrogen, Carlsbad, CA). During immunofluorescence analysis, both the distribution and the
intensity of the immunoreactive signal were evaluated. Five 20X fields from each sample were
evaluated and selected for analysis. A total of 10 intercalated discs were selected and the
immunoreactive signal intensity of the protein tested was assessed with the software ImageJ
(National Institutes of Health, Bethesda, MD), as previously described (Gavet and Pines 2010).
The intensity per pixel of each intercalated disc was measured and the intensity per pixel of an
equally sized area of background adjacent to the intercalated disc was subtracted.
The following primary antibodies were tested: polyclonal rabbit anti-cadherin (Sigma
Aldrich, St. Louis, MO), polyclonal rabbit anti-desmoplakin (Santa Cruz Biotechnology, Inc.,
Santa Cruz, CA), monoclonal mouse anti-plakoglobin (Sigma Aldrich, St. Louis, MO),
polyclonal rabbit anti-connexin 43 (EMD Millipore, Billerica, MA), polyclonal rabbit anti21

connexin 40 (Invitrogen, Carlsbad, CA), polyclonal rabbit anti-connexin 45 (Santa Cruz
Biotechnology, Inc., Santa Cruz, CA) and monoclonal mouse anti-plakophilin 2a and 2b
(Meridian Life Science, Inc., Memphis, TN).
Immunochemical detection of intercalated disc proteins
Western blot was performed on left and right atrial samples of 14 control and 10 boxer
dogs. Frozen tissue samples were homogenized in Laemmli buffer and protein amount measured
by RC DC protein assay (Bio-Rad Laboratories, Inc., Hercules, CA). Proteins were separated by
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) using a 4% to 15%
precast polyacrylamide gradient gel (Bio-Rad Laboratories, Inc., Hercules, CA), transferred onto
nitrocellulose, blocked for 1 hour at room temperature with 5% non-fat milk in PBS-Tween
(0.2%), and then incubated overnight at 4°C with the appropriate primary antibodies. To ensure
equal loading, blots were stripped with Restore Western Blot Stripping Buffer (Thermo Fisher
Scientific, Inc., Rockford, IL), blocked once more with 5% non-fat milk in PBS-Tween for 1
hour at room temperature, and then incubated with anti-beta Actin antibody (Abcam, Cambridge,
MA). Western blot band relative density was calculated for all the protein tested using the
software ImageJ (National Institutes of Health, Bethesda, MD), as outlined in the ImageJ
documentation (Schneider, Rasband et al. 2012). Student’s t test was used to compare the left
and right atrial western blot band relative density, of each protein tested, of control dogs to that
of boxer dogs.
The following primary antibodies were used: polyclonal rabbit anti-cadherin (Sigma
Aldrich, St. Louis, MO), monoclonal mouse anti-desmoplakin (AbD Serotec, Kidlington, UK),
monoclonal mouse anti-plakoglobin (Sigma Aldrich, St. Louis, MO ), polyclonal rabbit anticonnexin 43 (EMD Millipore, Billerica, MA ), polyclonal rabbit anti-connexin 40 (Abcam,
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Cambridge, MA), polyclonal rabbit anti-connexin 45 (Santa Cruz Biotechnology, Inc., Santa
Cruz, CA ) and monoclonal mouse anti-plakophilin 2a and 2b (Meridian Life Science, Inc.,
Memphis, TN).
Transmission electron microscopy
Transmission electron microscopy was performed on left and right atrial samples of 2
control and 2 Boxer dogs. The samples were fixed for 1 hour with 1.25% glutaraldehyde and 2%
formaldehyde in 0.1M sodium CAC buffer, pH 7.4. After fixation, the samples were washed
overnight in 0.1M CAC buffer (pH 7.4) with 5% sucrose. They were then treated with osmium
tetroxide, dehydrated, infiltrated using increasing concentrations of epoxy resin and embedded in
epoxy resin. The tissue samples were sectioned to 75 nm thickness and stained with uranyl
acetate followed by Reynold’s lead citrate and examined using a JEOL JEM-1011 transmission
electron microscope equipped with AMT image capture engine. For each section, 3-5 different
fields were evaluated at 5,000X magnification. The fields were selected based on the quality of
the sectioning, lack of adipocyte infiltration (in AC dogs), and the amount of intercalated discs.
Images were obtained at 15,000X magnification following the course of the intercalated discs.
Statistical analysis
When indicated, results are expressed as mean ± SD or as median and range. D’Agostino
and Pearson normality test was used to test for Gaussian distribution. The western blot and
immunofluorescence data was compared using the Student’s t test when the data was normally
distributed data or the Mann-Whitney U test if the data was not normally distributed. All
calculations were performed using the statistical analysis software, GraphPad Prism version 5.0
(GraphPad Software, San Diego CA). A value of P<0.05 was considered statistically significant.
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Chapter 4
Results
Animals
The demographic data of the control and AC boxers is summarized in table 4.1. Hearts
were obtained from 14 controls with a median age of 5 months (range 5-7 months), mean weight
of 18.1 ± 2.7 kg, and 13 boxer dogs with a median age of 8 years (range 2-11 years), and a mean
Table 4.1. Demographic Data of Controls and AC
Boxers
Control
AC Boxer
Number of dogs

14

13

weight of 31.0 ± 3.6 kg. The control
dogs had a mean heart weight (g) to
body weight (kg) ratio of 6.99 ±
0.52. For the AC boxers, this ratio

5 months

8 years

(5-7 months)

(2-11 years)

Body weight (kg)

18.1 ± 2.7

31.0 ± 3.6

Sex

14 males

6 males

(dog #11). Seven boxers had

0 females

7 females

echocardiographic evidence of

1/14

5/13

Age

Intact

could be calculated in 3 dogs; it was
9 (dog #1), 8.37 (dog #5), and 9.21

myocardial failure, with increased

left ventricular end systolic diameter and decreased fractional shortening. Six boxers had atrial
dilation determined by a left atrium to aortic root ratio of >1.8 (Table 4.2). Nine boxers had
supraventricular ectopy (SVE) noted via electrocardiography or 24-hour Holter recording at the
time of the first evaluation before the administration of antiarrhythmic medication. The SVE
were most commonly atrial premature complexes, couplets or triplets (6 boxers), followed by
supraventricular tachycardia (2 boxers) and atrial fibrillation (1 boxer). The number of
supraventricular ectopic beats, in 24 hours, for the 6 boxers with atrial premature complexes are
reported in table 4.2. Ventricular ectopy with a wide positive R wave in leads II, III and aVF was
the predominant arrhythmia in all the boxers with the exception of two boxers who had primarily
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SVE (dog #3 with supraventricular tachycardia and dog #11 with atrial fibrillation). Six boxers
had a history of syncopal episodes. The results of genetic testing for the striatin mutation were
available in 5 boxers. Out of these 5 boxers, 2 were heterozygous (dog #6 and dog #13), 1 was
homozygous (dog #4) and 2 were negative (dog # 8 and dog #12) for the striatin mutation.
Table 4.2. Summary of Clinical Findings in 13 AC Boxers
Echocardiography
Dog #

Rhythm

Clinical signs

LVDD (cm)

LVSD (cm)

FS (%)

LA/Ao

1
2
3
4
5
6
7
8
9
10
11
12
13

SVT/VPC
VT
SVT/VPC
VT/APC (3)
VT/APC (18)
VT/APC (31)
VT
VT/APC (17)
VT
VT
AF
VPC/APC (1)
VT/APC (60)

S,PE
L
N
S
S,L
S
N
N
N
N
S
N
S

6.2
4.7
5.1
5.2
5.1
4.2
4.3
4
5
4
-

5.1
4.3
3.8
4.2
4.5
3.1
3
2.9
4.9
2.2
-

18
8.6
25.5
19
12
26
30
27.5
2
45
-

2.5
2.3
1.5
1.8
2.3
1.8
2.1
2
2.7
1.5
-

APC = atrial premature complexes; FS = percent fractional shortening; L = lethargy; LA/Ao = left
atrial/aortic root ratio; LVDD = left ventricular diastolic diameter; LVDS = left ventricular systolic
diameter; N = no clinical signs; PE = pulmonary edema; S = syncope; SVT = supraventricular tachycardia;
VPC = ventricular premature complexes; VT = ventricular tachycardia. Number in parenthesis represents
the number of supraventricular ectopic beats, in 24 hours.

Pathological findings
Upon histopathological evaluation, the tissues were classified as normal or as having
fatty or fibro-fatty myocardial replacement by a single investigator who was not aware of the
group status. All 13 boxers showed the characteristic histopathological lesions of AC, with fatty
(8/13) or fibro-fatty (5/13) replacement of the right ventricular myocardium. Left atrial lesions
were seen in 9 out of 12 boxers, with 8 classified as fatty and 1 classified as fibro-fatty
myocardial replacement (Figure 4.1 A and B). The left atrium was not available for evaluation in
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one boxer. Right atrial lesions were identified in 12 out of 13 boxers, with 7 classified as fatty
and 5 classified as fibro-fatty myocardial replacement (Figure 4.1 C-E). Two boxers had a
normal left atrium and right atrial changes (dog #1 and dog #3) and 1 boxer (dog #10) had a
normal left and right atrium. Inflammatory infiltrates suggestive of myocarditis were identified
in the atria of 5 out of 13 AC boxers; infiltrates were seen in the right atrium alone in 4 boxers
and in both the left and right atrium in 1 boxer. All the control dogs were classified as having
normal atrial and right ventricular myocardium.

Figure 4.1. Histopathology of the atrial myocardium from an AC boxer. (A) Left atrium
(10X) showing relatively heterogeneous atrial myocardium. Box highlights section depicted
in (B). (B) Higher magnification (30X) through the epicardium towards the mid mural
region. Small, scattered clusters of adipocytes are present. There is some vertical tissue
separation caused by processing artifact. (C) Right atrium showing generalized subepicardial
replacement of myocytes with adipocytes, and focal regions of atrial tissue with generalized
fatty infiltrate. Box contains the section highlighted to right. H&E, 10X. (D) Magnified
section from (C) showing fatty replacement of myocytes. Occasional small, atrophic
myocytes can be observed, surrounded by adipocytes. Mild interstitial fibrosis is present.
H&E, 70X. (E) Same section as (D) stained with Masson trichrome stain to illustrate
collagen (blue) located sub-epicardially and interstitially. 70X
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Localization of intercalated disc proteins by immunofluorescence
Immunofluorescence analysis was conducted on the left and right atrial sections for the
following proteins: cadherin, PKP-2, DP, JUP (adherens junctions and desmosomes), Cx40,
Cx43, and Cx45.
Based on our samples we could not see a difference in the distribution of the
immunoreactive signal for the adherens junctions and desmosomal proteins evaluated; nor was
there a difference for the gap junction protein Cx40. No immunoreactive signal for Cx45 was
detected in the samples collected. A decrease in the number of Cx43 signals per 20X field was
noted in the left and right atrium of AC boxers compared to the controls (Figure 4.2). However,
the immunoreactive signal intensity for Cx43 was not different between the groups (Figure 4.2
and 4.3). Likewise, there was no difference in the immunoreactive signal for cadherin, Cx40,
desmoplakin, and PKP-2 (Figure 4.3).

Figure 4.2. Immunofluorescence of Connexin 43 showing decreased density of Cx43 in the
AC boxers. The bright green fluorescence represents Cx43 and the blue fluorescence is DAPI
staining the nucleus. (A) left atrium control dog, (B) left atrium AC boxer, (C) right atrium
control dog, (D) right atrium boxer. Scale bars denote 50 μm.
27

Figure 4.3. Optical density calculations of the immunoreactive signal from cadherin,
Cx40, Cx43, DP, JUP, and PKP-2. The immunoreactive signal for JUP is decreased in the
left and right atrium of the AC boxers. (*=P<0.05 and **=P<0.01)

The JUP immunoreactive signal intensity was significantly decreased in the right atrium
of AC boxers when compared to the right atrium of the control dogs (optical density 6.19 ± 2.06
versus 11.05 ± 5.31, P=0.009) (Figure 4.3 and 4.4). Similarly, the immunoreactive signal
intensity for JUP was decreased in the left atrium of boxers when compared to the left atrium of
the control dogs (optical density 7.53 ± 2.21 versus 10.15 ± 2.89, P=0.032) (Figure 4.3 and 4.4).
Two boxers (dog #9 and #10) showed almost no detectable signal. Overall, the
immunofluorescence results suggest the presence of altered desmosomal proteins and gap
junction remodeling in the atrial myocardium of AC afflicted boxers.
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Figure 4.4. Immunofluorescence for Plakoglobin showing decreased JUP immunoreactive
signal in the AC boxers. The bright red fluorescence represents JUP and the blue
fluorescence is DAPI staining the nucleus. (A) left atrium control dog, (B) left atrium AC
boxer, (C) right atrium control dog, (D) right atrium boxer. Scale bars denote 50 μm.
Immunochemical detection of intercalated disc proteins
Western blot was performed from the left and right atrial tissue lysates for the same
proteins evaluated via immunofluorescence. There was no difference in the western blot band
density for the desmosomal proteins: JUP, PKP2, DP or Cadherin (Figure 4.5).

Figure 4.5. Representative western blots for Cadherin (Cad), Connexin 40 (Cx40),
Connexin 45 (Cx45), Desmoplakin (DP), Plakoglobin (JUP), Plakophilin-2 (PKP2) and
actin (loading control). (1) left atrium control, (2) left atrium AC boxer, (3) right atrium
control, (4) right atrium boxer.
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Similarly there was no difference in the band density for the gap junction proteins Cx40
and Cx45 (Figure 4.5). However, the band density for connexin 43 was significantly decreased in
the right atrium of AC boxers compared to the controls (band density Cx43/Actin 0.68 +/- 0.23
versus 1.115 +/- 0.3, P=0.004) (Figure 4.6). Connexin 43 also appeared to be decreased in the
left atrium; however this did not reach statistical significance, P=0.18. Overall, these results
suggest a reduction in the total protein content of connexin 43 in the atria of AC afflicted boxers.

Figure 4.6. Representative western blot for Cx43 and actin (loading control) showing
decreased Cx43 in the right atrium of the AC boxers. The left atrium also appeared to have
decreased Cx43 however this did not reach statistical significance. (*= P<0.05)
Transmission electron microscopy
Transmission electron microscopy was performed in the left and right atrial samples of 2
boxers and 2 controls. Adipocytes were identified in between the cardiomyocytes in the boxers
but not in the controls (Figure 4.7). In the AC boxers, some areas of the intercalated disc
appeared widened and altered in structure with the presence internalized gap junctions (Figure
4.7), potentially indicating an increased remodeling of the intercalated disc of boxers with AC.
The TEM results suggest that boxers afflicted with AC have disruption of the intercalated disc in
the atrial myocardium.
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Figure 4.7. Electron micrograph of the intercalated disc (white arrows) showing the
presence of adipocyte infiltration (black arrows) and disruption of the intercalated disc
(black asterisk) in an AC boxers. Area inside the box shows the intercalated disc in a control
dog. Scale bar denotes 500 nm
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Chapter 5
Discussion and Conclusion
Arrhythmogenic cardiomyopathy is also known as arrhythmogenic right ventricular
cardiomyopathy as it was previously described as a disease affecting solely the right ventricular
myocardium; now it is widely accepted that the disease can also affect the left ventricular
myocardium (Asimaki and Saffitz 2012). However, it is unknown to what degree the atrial
myocardium is affected by AC. The present study was designed to determine if the atrial
myocardium of boxers with AC is also affected by the disease and whether alterations to the
intercalated disc proteins are present in the atrial tissue of boxers with AC. The major findings
were: 1) the presence of supraventricular arrhythmias in the AC boxers; 2) the atrial myocardium
of the AC boxers has histopathological changes consistent with AC; 3) decreased JUP
immunoreactive signal intensity without a change in the total western blot protein concentration;
4) decreased number of Cx43 immunoreactive signals with a decreased in the western blot
protein concentration.
The Holter monitor data shows that even though AC is a disease dominated by
ventricular arrhythmias, supraventricular ectopy was noted in 9 out of 13 boxers in the current
study. In the majority of the boxers these arrhythmias were mild and of no clinical concern.
However, in two boxers (dog # 3 and dog #11) supraventricular arrhythmia was the predominant
rhythm. While most of the attention has been directed to the life-threatening ventricular
arrhythmias it is important that when present the atrial arrhythmias are not ignored. If severe
enough, these arrhythmias could also lead to syncope or contribute to the progression to heart
failure (Nogami, Adachi et al. 1990; Shinbane, Wood et al. 1997). Atrial arrhythmias can be the
result of atrial dilation and fibrosis secondary to heart failure (Burstein, Comtois et al. 2009). It is
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possible that the arrhythmias seen in our study population were caused by atrial dilation and
fibrosis secondary to heart failure, as the majority (60%) of the boxers had atrial dilation. For
example the boxer with atrial fibrillation (dog #11) had the largest left atrium to aortic root ratio
in our study population. Interestingly, the boxer with primarily SVT (dog #3) had no atrial
dilation, suggesting that AC may contribute to the atrial arrhythmias independently of atrial
dilation.
Blinded histopathological assessment showed changes characteristic of AC in the atria of
12 out of the 13 boxers and in none of the controls. The quality of the atrial sections for the
boxer described to have no changes consistent with AC was poor, potentially contributing to an
incorrect histopathological classification. The fatty or fibro-fatty myocardial replacement was
present in the atria of boxer regardless of the presence of SVE. Atrial histopathological changes
characteristic of AC have been reported previously in 8 out of 23 boxers in the first report of AC
in this breed (Basso, Fox et al. 2004). Inflammatory infiltrates suggestive of myocarditis were
identified in the atria of 38% of the AC boxers in our study population. Inflammatory infiltrates
characteristic of myocarditis have been reported in the right ventricle (61%), left ventricle (70%),
and atria (17%) of AC boxers (Basso, Fox et al. 2004). These results indicate that even though
AC has been reported to primarily affect the right and less frequently the left ventricular
myocardium, the atrial myocardium is also affected by the disease. The fatty or fibro-fatty
replacement of the atrial myocardium could represent the substrate for the atrial arrhythmias in
AC boxers. However, the present study does not provide a direct link between the atrial
arrhythmias and AC.
In order to further characterize the extent to which AC affects the atrial myocardium, we
investigated whether alterations in the desmosomal proteins and gap junctions were present in
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these boxers. Immunofluorescence analysis of the tissue showed that the cadherin
immunoreactive signal intensity was similar to that of the controls, a finding that is consistent
with other reports (Kaplan, Gard et al. 2004; Oxford, Everitt et al. 2007; Asimaki, Tandri et al.
2009). We failed to identify a difference in the immunoreactive signal intensity level for PKP2
and DP. In human AC, it has been shown that a decrease in the ventricular immunoreactive
signal intensity for these proteins is variable and appears to be related to the type of genetic
mutation (Asimaki, Tandri et al. 2009). A similar finding has been shown in boxers, with the
ventricular immunoreactive signal intensity for PKP2 and DP having more variability in affected
patients (Oxford, Everitt et al. 2007). On the other hand, a decrease in the ventricular
immunoreactive signal intensity for JUP appears to be a more consistent finding in boxers,
something that has also been shown in humans with AC regardless of the kind of genetic
mutation (Oxford, Everitt et al. 2007; Asimaki, Tandri et al. 2009). This decrease in ventricular
immunoreactive signal intensity for JUP has been shown to be 91% sensitive and 82% specific
for the diagnosis of AC in humans (Asimaki, Tandri et al. 2009). In our population we found
loss of the atrial immunoreactive signal intensity for JUP in the intercalated disc of AC boxers.
Yet, western blot analysis demonstrated normal expression of JUP. Western blot has previously
failed to detect a difference in the expression of desmosomal proteins (JUP, PKP2, DP) in the
ventricular tissue of both humans and boxers with AC, suggesting that the loss of
immunoreactive signal intensity is not due to loss of the total protein content in the myocyte, but
likely results from failure of the altered proteins to appropriately incorporate in the desmosome
preventing the formation of functional desmosomal units at the level of the intercalated disc
(Kaplan, Gard et al. 2004; Oxford, Everitt et al. 2007; Asimaki, Tandri et al. 2009). The
decrease in the immunoreactive signal intensity for JUP serves as an additional indication that
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alterations to the atrial intercalated disc are present in boxer AC. However, a specific link
between the alterations to the intercalated disc proteins such as JUP and the fatty or fibro-fatty
myocardial replacement that characterizes AC has not been established. It has been suggested
that the incorporation of abnormal desmosomal proteins into the intercalated disc leads to
disruption of the mechanical coupling provided by the desmosome and that it facilitates myocyte
detachment leading to cell injury, apoptosis, and the development of fatty or fibro-fatty
myocardial replacement (Corrado, Basso et al. 2011; Asimaki and Saffitz 2012). This hypothesis
appears to be a simplistic view of the disease process in AC, as it has been shown that
desmosomal proteins also regulate changes in signaling pathways. Importantly, nuclear
translocation of plakoglobin, in desmoplakin deficient mice, mediates changes in the Wnt
pathway resulting in fibrosis, fatty replacement of the myocardium and ventricular arrhythmias
(Garcia-Gras, Lombardi et al. 2006; Delmar and McKenna 2010). It is likely that both the
altered mechanical load and the interaction of the abnormal desmosomal proteins with signaling
pathways contribute to the disease process in AC.
Previous studies evaluating Cx43 in the ventricular tissue of both humans and boxers
affected with AC have shown decreased Cx43 immunoreactive signal intensity and altered
localization, to the lateral aspect of the myocytes instead of forming part of the end to end
connections (Kaplan, Gard et al. 2004; Oxford, Everitt et al. 2007). In the present study, the
“lateralization” of Cx43 could not be examined as the atrial myocardium normally expresses gap
junctions at the site of end to end cell apposition and on the lateral aspect of the myocytes
(Severs, Bruce et al. 2008). In the present study we did not see a decrease in the immunoreactive
signal intensity for Cx43. However, a decrease in the number of Cx43 signals was noted via
immunofluorescence in the AC boxers. The decrease in the amount of Cx43 was confirmed by
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western blot analysis in the right atrium. Connexin 43 also appeared be decreased in the left
atrium; however this did not reach statistical significance. We also failed to identify a difference
between the control and AC boxers for Cx40 and Cx45. These proteins have been shown to be
expressed in the atrial myocardium of dogs as part of the gap junction; however they have not
been previously evaluated in AC affected animals (Davis, Kanter et al. 1994). No
immunoreactive signal for Cx45 was noted in the samples collected, yet weak Cx45 bands were
detected via western blot. It is possible that the anti-connexin 45 antibody did not yield an
adequate signal with the immunofluorescence protocol used, or more likely there was minimal
expression in the atrial samples collected, as Cx45 is primarily found in the sinus and
atrioventricular node (Giovannone, Remo et al. 2012). The amount of Cx45 present is these
samples was likely below our level of detection via immunofluorescence but still identifiable
with western blot (Oxford, Everitt et al. 2007). Overall the changes seen via
immunofluorescence and western blot suggest the presence of gap junction remodeling in the
atria of AC affected boxers. Although gap junctions have not been shown to be directly affected
by AC, their remodeling has been shown to occur in the ventricular tissue of both humans and
boxers with AC (Kaplan, Gard et al. 2004; Kaplan, Gard et al. 2004; Oxford, Everitt et al. 2007).
It is believed that normal gap junction function is dependent on the mechanical coupling
provided by the desmosomes (Asimaki and Saffitz 2012). Therefore, once the mechanical
connection provided by desmosomes has been disrupted, the gap junctions cannot sustain the
remaining forces and remodeling occurs. This mechanism could explain why transmission
electron microscopy of the atrial myocardium in the AC boxers showed internalized gap
junctions near the widened altered structure sections of the intercalated disc. Signaling pathways
triggered by the altered mechanical load, interaction with abnormal desmosomal proteins and
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cytokine production are also suspected to play a role in gap junction remodeling (Asimaki and
Saffitz 2012). For example, decreased expression of PKP-2 in cultured myocytes leads to
decreased Cx43 expression, suggesting that increase mechanical load is not the only factor
leading to gap junction remodeling in AC (Oxford, Musa et al. 2007). Alterations to gap
junction structure and function may lead to arrhythmogenesis (Severs, Bruce et al. 2008). For
example, heterogeneous Cx43 expression in the myocardium of chimeric mice was linked to
conduction abnormalities and occasional ventricular tachycardia (Gutstein, Morley et al. 2001).
Our results are consistent with the notion that gap junction remodeling may contribute to the
arrhythmogenic substrate created by the fatty or fibro-fatty myocardial replacement in AC.
However, it should be noted that functional measurements evaluating this hypothesis have not
been performed, as the majority of the studies evaluating gap junction remodeling in AC have
been based on immunohistochemistry, which does not provide information about function or
conduction changes (Asimaki and Saffitz 2012; Duffy 2012).
Transmission electron microscopy showed adipocyte infiltration and areas of widened,
altered structure of the intercalated disc in the AC boxers. Previous TEM studies in boxers and
humans have shown adipocyte infiltration and a significantly lower number of desmosomes in
the right ventricle of AC affected individuals compared to controls (Basso, Czarnowska et al.
2006; Oxford, Danko et al. 2011). Quantification of the numbers of desmosomes was not
possible in the present study due the small number of dogs evaluated with TEM.
There are some limitations to in the interpretation of our results. Our results are based on
a small number of boxers with AC and non-age matched healthy control. Ideally age matched
boxers without AC would serve as controls. However, there is no test to ascertain that a healthy
boxer is not an asymptomatic carrier of the disease. The TEM results are based on the
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assessment of only 2 boxers, therefore additional samples are needed for evaluation and analysis
of the ultrastructural changes in atrial myocytes of boxers with AC. Another limitation is that
postmortem changes to the tissues that may alter our molecular results, as loss of intercalated
disk integrity and gap junction remodeling, can occur soon after death. To minimize this risk,
cardiac tissues were collected no longer than 1 hour after euthanasia, and Cx43 has been shown
to be stable for 2 hours (Oxford, Everitt et al. 2007). We did not evaluate the location or
expression of the striatin protein via immunofluorescence or western blot in these boxers.
Genetic testing was performed in 5 out of the 13 boxers as part of their clinical evaluation;
however, some of the boxer tissue was collected prior to the discovery of the striatin mutation
and therefore DNA was not stored for genetic testing. The majority of the boxers in the study
were euthanized because of end stage AC. Therefore, it is possible that the molecular changes
seen in this study are due to the end stage cardiac disease and heart failure rather than changes
secondary to AC (Vatta, Marcus et al. 2007). Lateralization and decreased Cx43 signal has been
shown to occur secondary to myocardial infarction and congestive heart failure (Severs, Bruce et
al. 2008; Kieken, Mutsaers et al. 2009). However, decreased expression of Cx43 and JUP has
been shown to occur in a patient with Naxos disease, a recessive form of AC with cutaneous
phenotype, before the presence of cardiac pathology (Kaplan, Gard et al. 2004). This suggests
that the alterations in JUP and Cx43 do occur secondary to AC instead of being the result of
congestive heart failure and end stage disease. Additional studies evaluating the expression of
Cx43 and JUP in dogs with congestive heart failure due to diseases other than AC and in boxers
with early AC would be needed for confirmation.
The present study shows that the atrial myocardium of boxers with AC has histologic
changes consistent with AC, decrease connexin 43 seen via immunofluorescence and western
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blot, and weaker immunoreactive signal intensity for plakoglobin. Together, the results indicate
that in addition to the ventricular myocardium, the atrial myocardium is affected in boxers with
AC. These findings support the use of the broader term of arrhythmogenic cardiomyopathy
rather than arrhythmogenic right ventricular cardiomyopathy to describe this disease. The
decrease in the amount of Cx43 in conjunction with the histological changes could represent the
substrate for the atrial arrhythmias associated with AC.
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